Canakinumab Explored as Therapy for Large-Joint Osteoarthritis

MONDAY, Aug. 3, 2020 -- Inhibition of interleukin-1β (IL-1β) with canakinumab seems to reduce the incidence of total hip replacement/total knee replacement (THR/TKR) compared with placebo, according to an exploratory analysis published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news